INSM

141.3302.17%
LL

Leo Lee

Independent Director

Mr. Leo Lee has been Director of Insmed Incorporated since May 17, 2018. Mr. Lee served as Chief Executive Officer and Executive Director at Cambium Bio Limited (formerly known as Regeneus Ltd.) since January 23, 2019 until November 2, 2020. He has experience in the pharmaceutical industry in Japan. Most recently, Mr. Lee worked with Merck KGaA, a global pharmaceutical company, where he served as President, Japan from 2015 to 2017. Prior to that, He served as President of Japan at Novartis Pharma since 2020. Mr. Lee served as President, Japan of Allergan plc, a global pharmaceutical company, from 2011 to 2015. Mr. Lee served as Vice President of Sales at Merck & Co. from 2008 to 2011. From 2003 to 2008, Mr. Lee held various commercial positions at IQVIA (Cegedim Dendrite), a life sciences services company, including General Manager (2007-2008), Vice President of Sales and Marketing, Asia Pacific (2006-2007) and Director of Global Accounts Operations, Asia (2003-2005). Mr. Lee also served in various roles at Accelrys, Inc. a software company serving pharmaceutical and biotech companies, from 1997 to 2003, including Senior Director of Western Regional Sales (2003), President and Representative Director (2000-2002), General Manager of Asia Pacific (1998-2000) and Sales Manager for Asia Pacific (1997-1998). Mr. Lee served as a Non-Executive Director at Cambium Bio Limited (formerly known as Regeneus Ltd.) since December 11, 2017 until April 5, 2024. Mr. Lee received a B.S. in Molecular Genetics and Microbiology from the University of California, Los Angeles.

Positions